We found that APOA4 and TUBA1A had the same expression pattern in the three experiments and may serve as novel potential biomarkers for complications of OSA, such as cardiovascular disease, cognitive dysfunction, and male hypogonadism. This evidence concerns the gene TUBA1A and cardiovascular disorder.